Renal Cell Carcinoma New Reference: Pembrolizumab and Lenvatinib for Advanced Non-Clear-Cell RCC Ulas D. Bayraktar, MD 2023-08-20
Renal Cell Carcinoma New Protocol: Belzutifan and Cabozantinib for Advanced RCC Ulas D. Bayraktar, MD 2023-06-24
Renal Cell Carcinoma New Reference: Nivolumab and Cabozantinib for Advanced RCC Ulas D. Bayraktar, MD 2022-09-20
